Alzamend Neuro, Inc. (ALZN)

NASDAQ: ALZN · Real-Time Price · USD

2.900

-0.030 (-1.02%)

At close: Jun 25, 2025, 4:00 PM

2.990

+0.090 (3.10%)

Pre-market: Jun 26, 2025, 8:38 AM EDT

Alzamend Neuro Income Statement

Financials in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2019
Period Ending	Jan '25 Jan 31, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022	Apr '21 Apr 30, 2021	Apr '20 Apr 30, 2020	2016 - 2019
Selling, General & Admin	3.06	3.48	7.42	7.12	3.64	3.35	Upgrade
Research & Development	1.15	6.46	7.45	5.2	1.31	1.07	Upgrade
Operating Expenses	4.21	9.94	14.87	12.32	4.95	4.42	Upgrade
Operating Income	-4.21	-9.94	-14.87	-12.32	-4.95	-4.42	Upgrade
Interest Expense	-0.02	-0.01	-0.01	-0.05	-0.16	-	Upgrade
Interest & Investment Income	-	-	-	-	0	0.01	Upgrade
EBT Excluding Unusual Items	-4.23	-9.95	-14.88	-12.37	-5.11	-4.41	Upgrade
Other Unusual Items	-	-	-	0	0.06	-	Upgrade
Pretax Income	-4.23	-9.95	-14.88	-12.36	-5.05	-4.41	Upgrade
Net Income	-4.23	-9.95	-14.88	-12.36	-5.05	-4.41	Upgrade
Net Income to Common	-4.23	-9.95	-14.88	-12.36	-5.05	-4.41	Upgrade
Shares Outstanding (Basic)	0	0	0	0	0	0	Upgrade
Shares Outstanding (Diluted)	0	0	0	0	0	0	Upgrade
Shares Change (YoY)	294.83%	4.07%	9.45%	22.64%	1.96%	21.09%	Upgrade
EPS (Basic)	-14.47	-132.33	-205.97	-187.31	-93.78	-83.56	Upgrade
EPS (Diluted)	-14.47	-132.33	-205.97	-187.31	-93.78	-83.56	Upgrade
Free Cash Flow	-7.4	-8.42	-8.92	-6.72	-2.71	-2.35	Upgrade
Free Cash Flow Per Share	-25.32	-111.97	-123.53	-101.83	-50.40	-44.45	Upgrade
EBITDA	-4.16	-9.89	-14.85	-12.32	-	-	Upgrade
D&A For EBITDA	0.05	0.05	0.02	0	-	-	Upgrade
EBIT	-4.21	-9.94	-14.87	-12.32	-4.95	-4.42	Upgrade

Updated Mar 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q